Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03425474Phase 3Completed
A Phase 3 trial of remimazolam in Procedural sedation (PS), sponsored by Hengrui. Started Sep 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03425474.